IFN-beta1a (Rebif) modifies the expression of microfilament-associated cell-cell contacts in C6 glioma cells

Area of Science:

• Neuroimmunology
• Cellular Biology
• Pathogenesis of Multiple Sclerosis

Background:

• Multiple sclerosis (MS) is a CNS inflammatory disease impacting the blood-brain barrier (BBB) and glial cells.
• Astrocytic intercellular contacts are crucial for BBB integrity.
• Proinflammatory cytokines like interferon-gamma (IFN-gamma) disrupt the BBB.

Purpose of the Study:

• To investigate the effect of recombinant interferon-gamma (rIFN-gamma) on astrocytic cell adhesion molecules.
• To determine if interferon-beta1a (IFN-beta1a), an MS therapeutic, influences these adhesion molecules.
• To explore IFN-beta1a's potential role in modulating astrocyte intercellular contacts in MS pathogenesis.

Main Methods:

• Western blot and immunofluorescence microscopy to assess N-cadherin and vinculin expression in C6 astrocytic cells.
• Co-culture experiments with human T lymphocytes and C6 cells to evaluate IFN-beta1a's effects.
• Stimulation with phytohemagglutinin (PHA) to induce IFN-gamma secretion.

Main Results:

• rIFN-gamma downregulated N-cadherin and vinculin expression in C6 cells.
• IFN-beta1a increased N-cadherin and vinculin expression in C6 cells.
• IFN-beta1a partially inhibited IFN-gamma-induced downregulation of these molecules in co-cultures.

Conclusions:

• IFN-beta1a modulates N-cadherin and vinculin-mediated intercellular contacts in astrocytes in vitro.
• These effects on astrocytic cell adhesion may contribute to the therapeutic efficacy of IFN-beta1a in MS.
• Understanding these molecular mechanisms can inform future MS treatment strategies.